"Since starting Ampyra, I have the confidence in my ability to do simple things, like keeping up? to meet friends" -Kristie

Is AMPYRA Right for You?

Talk to your healthcare team. Ask if AMPYRA may be right for you

Discussing your walking with your doctor is important. Walking might affect other aspects of your life, from crossing the street in time to make the light, meeting friends at a nearby coffee house, or enjoying a walk with your family.

If you have noticed changes in your walking don’t wait, talk to your healthcare provider to see if AMPYRA® (dalfampridine) may be right for you.

The Talking to Your Doctor Discussion Guide can start the conversation. It's a free tool to help you assess your walking so you can prepare for your next doctor's visit and explain what you are experiencing.

Take a walking self-assessment as part of the Talking to Your Doctor Discussion Guide

AMPYRA Conversations

Watch a one-on-one interview with an MS nurse practitioner as she talks about real-life examples one should look for to assess changes in walking when deciding if AMPYRA may be right for you.

AMPYRA is indicated as a treatment to improve walking in patients with MS. AMPYRA improved walking in significantly more people with MS than placebo (sugar pill) in two clinical trials (34.8% vs. 8.3% and 42.9% vs. 9.3%). This was demonstrated by an increase in walking speed.

Not everyone responds to AMPYRA. Individual results may vary.

What should someone look for to know if their walking has changed?
Open to see text version
Kristie Salerno Kent:

When you discuss walking with patients, what kind of questions do you ask them?

Tracy Walker:

I usually ask patients, you know, "What kind of activities of daily living uh.. are affected by your walking? Can you still clean? Can you still cook? Can you get to the bathroom on time?" You know, important things like that. Is that-- are those being affected uh.. by the walking?

Kristie Salerno Kent is a paid spokesperson for Acorda Therapeutics®, Inc. Kristie is living with MS and is currently taking AMPYRA. The people interviewed by Kristie for the AMPYRA Conversations video series are real people living with MS and real healthcare professionals who treat people with MS. All participants have been compensated for their time.

Can I take AMPYRA with my current multiple sclerosis (MS) medication?

Yes, you can take AMPYRA even if you are taking other medications for MS, including disease-modifying therapies. AMPYRA is not meant to replace your current MS medication.

AMPYRA can be taken alone or with your other MS medications. It can be taken by people with any of the four major types of MS.

Who shouldn't take AMPYRA?

Talk to your doctor to see if AMPYRA may be right for you. Do not take AMPYRA if you have ever had a seizure or have certain types of kidney problems, or are allergic to dalfampridine (4-aminopyridine), the active ingredient in AMPYRA.

What should I tell my doctor before I start taking AMPYRA?

You must tell your doctor if you have ever had a seizure or if you have kidney problems or if you are allergic to dalfampridine (4-aminopyridine), the active ingredient in AMPYRA.

Tell your doctor if you are currently taking forms of 4-aminopyridine (fampridine, 4-AP). These have the same active ingredient as AMPYRA and should be stopped before taking AMPYRA.

Also tell your doctor if you are pregnant or plan to become pregnant. It is not known if AMPYRA will harm your unborn baby. You and your doctor will decide if you should take AMPYRA while you are pregnant.

You should also tell your doctor if you are breast-feeding or plan to breast-feed. It is not known if AMPYRA passes into breast milk. You and your doctor should decide if you will take AMPYRA or breast-feed. You should not do both.

AMPYRA® (dalfampridine) is indicated as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed.

IMPORTANT SAFETY INFORMATION

Do not take AMPYRA if you have ever had a seizure, or have certain types of kidney problems, or are allergic to dalfampridine (4-aminopyridine), the active ingredient in AMPYRA.

Take AMPYRA exactly as prescribed by your doctor.

You could have a seizure even if you never had a seizure before. Your chance of having a seizure is higher if you take too much AMPYRA or if your kidneys have a mild decrease of function, which is common after age 50.

Your doctor may do a blood test to check how well your kidneys are working, if that is not known before you start taking AMPYRA.

AMPYRA may cause serious allergic reactions. Stop taking AMPYRA and call your doctor right away or get emergency medical help if you have shortness of breath or trouble breathing, swelling of your throat or tongue, or hives.

AMPYRA should not be taken with other forms of 4-aminopyridine (4-AP, fampridine), since the active ingredient is the same.

The most common adverse events for AMPYRA in MS patients were urinary tract infection, trouble sleeping, dizziness, headache, nausea, weakness, back pain, and problems with balance.

Before taking AMPYRA tell your doctor if you are pregnant or plan to become pregnant. It is not known if AMPYRA will harm your unborn baby.

Tell your doctor if you are breast-feeding or plan to breast-feed. It is not known if AMPYRA passes into your breast milk. You and your doctor should decide if you will take AMPYRA or breast-feed. You should not do both.

Please see the full Prescribing Information and Patient Medication Guide.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

AMPYRA®, ACORDA THERAPEUTICS® and the stylized ACORDA THERAPEUTICS® logo are registered trademarks of Acorda Therapeutics, Inc. | AMPYRA® is marketed by Acorda Therapeutics, Inc. and manufactured under license from Alkermes Pharma Ireland Limited (APIL), Ireland. | AMPYRACONNECT™ is a trademark of Acorda Therapeutics, Inc. | The stylized path logo and the stylized Acorda logo are trademarks of Acorda Therapeutics, Inc. | © 2013 Acorda Therapeutics, Inc. All rights reserved.

AMP2043